Not applicableLooking for participantsNCT07458906
What this trial is testing
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
Who this might be right for
DLL3-expressing TumorsPET / CTNeuroendocrine Cancer
The First Affiliated Hospital of Xiamen University 80